(Reuters) – Moderna Inc said on Tuesday it has applied for full U.S. approval of its COVID-19 vaccine, which is currently only authorized for emergency use in the country.
The development comes weeks after rival Pfizer Inc and its German partner BioNTech SE sought full approval for their COVID-19 vaccine in the United States.
(Reporting by Amruta Khandekar in Bengaluru; Editing by Shounak Dasgupta)
